• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. The heart knows best: baseline heart rate variability as guide to transcutaneous auricular vagus nerve stimulation in depression
 
  • Details
  • Full
Options
2025
Journal Article
Title

The heart knows best: baseline heart rate variability as guide to transcutaneous auricular vagus nerve stimulation in depression

Abstract
Major Depressive Disorder can be conceptualized as a chronic stress condition associated with autonomic dysregulation, including blunted heart rate reactivity, elevated basal cortisol levels and higher low-grade peripheral inflammation, pointing to an autonomic imbalance with relative sympathetic overactivation and parasympathetic attenuation. Transcutaneous vagus nerve stimulation (taVNS) offers a non-invasive method to stimulate the vagus nerve, as key component of the parasympathetic system, to restore autonomic balance. Here, we examined whether emotional (i.e., positive and negative emotions), cardiac (i.e., heart rate and heart rate variability (HRV)), and inflammatory (i.e., TNF- α, IL-6) reactivity to stress are differentially influenced by taVNS in participants with MDD and controls. Additionally, we performed a post-hoc analysis with participants stratified by baseline RMSSD, as a proxy for vagus nerve activity, to evaluate the utility of biological stratification beyond diagnostic criteria. To assess the effect of chronic stress we conducted a single-blinded, cross-over, randomized controlled trial with 110 participants (51 controls and 59 MDD participants). For the analysis stratified by RMSSD group, we grouped participants into low (n = 54) vs. high (n = 55) RMSSD groups, regardless of diagnosis. All participants were subjected to an acute stress paradigm, both with taVNS and sham stimulation on two separate days, in a counter-balanced order. There was no difference in any of the outcomes regarding the effect of taVNS in participants with MDD and controls. Analyses split by RMSSD group, however, showed that for those with low RMSSD, taVNS restored the blunted cardiac stress response and numerically decreased TNF-α levels. Unexpectedly, in participants with high RMSSD, the opposite pattern was observed: heart rate and TNF-α were significantly increased, and vagally mediated heart rate variability was significantly decreased under taVNS compared to sham stimulation. Analyses using RMSSD as continuous predictor yielded similar results. Our findings suggest that RMSSD-based stratification may be a useful tool for predicting outcome of (ta)VNS treatment. We encourage researchers with HRV data to re-evaluate their findings through RMSSD stratification.
Author(s)
Schiweck, Carmen
Universitätsklinikum Frankfurt
Aichholzer, Mareike
Universitätsklinikum Frankfurt
Brandt, Emily
Universitätsklinikum Frankfurt
Schneider, Moritz
Universitätsklinikum Frankfurt
Meyer, Konrad
Universitätsklinikum Frankfurt
Hamzehloiya, Tirage
Universitätsklinikum Frankfurt
Qubad, Mishal
Universitätsklinikum Frankfurt
Uckermark, Carmen
Universitätsklinikum Frankfurt
Jacobsen, Leona
Universitätsklinikum Frankfurt
Amaral, Kevin
Universitätsklinikum Frankfurt
Auer, Joyce
Universitätsklinikum Frankfurt
Bruno, Gianluca
Universitätsklinikum Frankfurt
Zhao, Tong
Universitätsklinikum Frankfurt
Bouzouina, Aicha
Universitätsklinikum Frankfurt
Schillo, Susanne
Universitätsklinikum Frankfurt
Hanssen, Ruth
Universität zu Köln
Hahn, Tim
University of Münster
Repple, Jonathan
Universitätsklinikum Frankfurt
Matura, Silke
Universitätsklinikum Frankfurt
Kingslake, Jonathan A.
P1vital Limited
Reif, Andreas
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Edwin Thanarajah, Sharmili
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Journal
Translational Psychiatry  
Open Access
File(s)
Download (1.74 MB)
Rights
CC BY 4.0: Creative Commons Attribution
DOI
10.1038/s41398-025-03780-y
10.24406/publica-7482
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024